NGS Panel of Incomplete Forms of Ocular Albinism

NCT04495218 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 53

Last updated 2024-09-19

No results posted yet for this study

Summary

Implementation of a next-generation sequencing panel of genes to identify deleterious variants in patients with incomplete forms of albinism.

Conditions

  • Albinism, Ocular

Interventions

BIOLOGICAL

Blood samples

Performed a 10 ml blood sample (2 unnamed samples of 5ml) in each of the 100 patients included.

Sponsors & Collaborators

  • University Hospital, Bordeaux

    lead OTHER

Eligibility

Min Age
0 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-23
Primary Completion
2024-02-28
Completion
2024-02-28

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04495218 on ClinicalTrials.gov